These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10987022)

  • 21. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer.
    Gavioli M; Luppi G; Losi L; Bertolini F; Santantonio M; Falchi AM; D'Amico R; Conte PF; Natalini G
    Dis Colon Rectum; 2005 Oct; 48(10):1851-7. PubMed ID: 16132481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of colorectal cancer.
    Påhlman L
    Ann Chir Gynaecol; 2000; 89(3):216-20. PubMed ID: 11079791
    [No Abstract]   [Full Text] [Related]  

  • 23. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication].
    Junginger T; Hermanek P; Oberholzer K; Schmidberger H
    Zentralbl Chir; 2006 Aug; 131(4):275-84. PubMed ID: 17004186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
    Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
    Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of local surgical therapy for rectal cancer. A literature analysis].
    Borschitz T; Junginger T
    Zentralbl Chir; 2003 Dec; 128(12):1066-74. PubMed ID: 14750068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invited commentary.
    Tudorica A; Thomas CR; Huang W
    Radiographics; 2010 May; 30(3):716-9; discussion 719-20. PubMed ID: 20480547
    [No Abstract]   [Full Text] [Related]  

  • 27. Is sentinel node biopsy necessary in conservatively treated DCIS?
    Julian TB; Land SR; Fourchotte V; Haile SR; Fisher ER; Mamounas EP; Costantino JP; Wolmark N
    Ann Surg Oncol; 2007 Aug; 14(8):2202-8. PubMed ID: 17534687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer].
    Tiefenbacher U; Wenz F
    Strahlenther Onkol; 2001 Dec; 177(12):682-4. PubMed ID: 11789410
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized controlled trials in surgical oncology: where do we stand?
    Mathis KL; Nelson H
    Surg Oncol Clin N Am; 2012 Jul; 21(3):449-66, ix. PubMed ID: 22583993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention and management of local recurrence of rectal carcinoma].
    Haddad R; Wolf Y; Skornick Y; Werbin N
    Harefuah; 1998 Dec; 135(11):528-33. PubMed ID: 10911472
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of pelvic recurrence by preoperative radiochemotherapy and total mesorectal excision of rectal carcinoma?].
    Bosset JF; Horiot JC
    Praxis (Bern 1994); 2001 Apr; 90(14):581-6. PubMed ID: 11320885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local excision of rectal carcinoma.
    Chorost MI; Petrelli NJ; McKenna M; Kraybill WG; Rodriguez-Bigas MA
    Am Surg; 2001 Aug; 67(8):774-9. PubMed ID: 11510582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative radiotherapy for stage IIIA rectal cancer: is it justified?
    Kariv Y; Kariv R; Hammel JP; Lavery IC
    Dis Colon Rectum; 2008 Oct; 51(10):1459-66. PubMed ID: 18661186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy for resectable rectal adenocarcinoma.
    Hu KS; Harrison LB
    Semin Surg Oncol; 2000 Dec; 19(4):336-49. PubMed ID: 11241916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0): National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-21.
    Fisher ER; Costantino JP; Leon ME; Bandos H; Palekar AS; Fisher B; Wolmark N
    Cancer; 2007 Nov; 110(9):1929-36. PubMed ID: 17896781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence.
    Hohenberger W; Merkel S; Matzel K; Bittorf B; Papadopoulos T; Göhl J
    Colorectal Dis; 2006 Jan; 8(1):23-33. PubMed ID: 16519634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen in ductal carcinoma in situ.
    Daly MB
    Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival.
    Rosenberg R; Nekarda H; Zimmermann F; Becker K; Lordick F; Hofler H; Molls M; Siewert JR
    J Surg Oncol; 2008 Jan; 97(1):8-13. PubMed ID: 18085619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.